Virginia Retirement Systems’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$225K	Sell	82,250 -50	-0.1%	-$116	﹤0.01%	899
2025 Q3	$179K	Buy	+82,300	New	+$194K	﹤0.01%	908
2025 Q2	–	Sell	-31,000	Closed	-$103K	–	1012
2025 Q1	$103K	Buy	+31,000	New	+$160K	﹤0.01%	999
2023 Q2	–	Sell	-11,200	Closed	-$68.4K	–	1035
2023 Q1	$68.4K	Sell	11,200 -6,900	-38%	-$47.6K	﹤0.01%	1015
2022 Q4	$116K	Sell	18,100 -8,100	-31%	-$63.2K	﹤0.01%	1091
2022 Q3	$251K	Buy	+26,200	New	+$302K	﹤0.01%	996
2021 Q2	–	Sell	-7,900	Closed	-$250K	–	1081
2021 Q1	$250K	Sell	7,900 -1,700	-18%	-$70.5K	﹤0.01%	1034
2020 Q4	$445K	Buy	9,600 +400	+4%	+$15.9K	﹤0.01%	884
2020 Q3	$303K	Sell	9,200 -9,500	-51%	-$291K	﹤0.01%	927
2020 Q2	$513K	Sell	18,700 -1,900	-9%	-$62.5K	0.01%	786
2020 Q1	$617K	Buy	20,600 +300	+1%	+$7.95K	0.01%	724
2019 Q4	$562K	Buy	+20,300	New	+$462K	0.01%	898